G1 Therapeutics Provides Second Quarter 2022 Financial Results and Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. ENOV
7. AON
8. AZN
9. BLSM
10. A

Go back to G1 Therapeutics Provides Second Quarter 2022 Financial Results and Operational Highlights

G1 Therapeutics, Inc. (GTHX) Tops Q2 EPS by 10c

August 3, 2022 6:44 AM EDT

G1 Therapeutics, Inc. (NASDAQ: GTHX) reported Q2 EPS of ($0.92), $0.10 better than the analyst estimate of ($1.02). Revenue for the quarter came in at $10.57 million versus the consensus estimate of $9.09 million.

For earnings history and earnings-related data on G1 Therapeutics, Inc. (GTHX) click here.

... More